Fifth and most importantly, despite the positive effect of CCL2 on MBs and MTs in our in vitro results, which suggest that CCL2 is a potential therapeutic target for low muscle mass and/or sarcopenia, the relationship between CCL2 or CCR2 expression and sarcopenia parameters in humans remains to be determined. Here, CCR2 is linked to sarcopenia.